Quest Diagnostics Inc. logo

Quest Diagnostics Inc. (DGX)

Market Closed
3 Mar, 20:00
NYSE NYSE
$
208. 36
-1.89
-0.9%
After Hours
$
210. 90
+2.54 +1.22%
23.57B Market Cap
20.12 P/E Ratio
3.2% Div Yield
627,088 Volume
8.71 Eps
$ 210.25
Previous Close
Day Range
203.89 209.82
Year Range
157.2 213.5
Want to track DGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
DGX earnings report is expected in 48 days (20 Apr 2026)
Quest Diagnostics (DGX) Earnings Expected to Grow: Should You Buy?

Quest Diagnostics (DGX) Earnings Expected to Grow: Should You Buy?

Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 10 months ago
Here's How Quest Diagnostics is Placed Ahead of Q1 Earnings

Here's How Quest Diagnostics is Placed Ahead of Q1 Earnings

DGX's first-quarter 2025 performance is likely to have been supported by the ongoing utilization of its Advanced Diagnostics and benefits from acquisitions.

Zacks | 10 months ago
DGX Stock Gains Following the Launch of New AD-Detect Blood Test

DGX Stock Gains Following the Launch of New AD-Detect Blood Test

Quest Diagnostics introduces AD-Detect Abeta, a new laboratory blood test, to detect Alzheimer's disease without any PET imaging and cerebral spinal fluid testing.

Zacks | 10 months ago
Is Quest Diagnostics Stock Worth Holding Onto Right Now?

Is Quest Diagnostics Stock Worth Holding Onto Right Now?

Strong momentum in Advanced Diagnostics and strategic acquisitions continues to attract investors to DGX.

Zacks | 11 months ago
DGX Stock Set to Benefit From New Google Cloud Partnership

DGX Stock Set to Benefit From New Google Cloud Partnership

Quest Diagnostics teams up with Google Cloud to streamline data and personalize customer experiences using gen AI.

Zacks | 11 months ago
Quest Diagnostics Stock Jumps 38% in a Year: What's Behind the Surge?

Quest Diagnostics Stock Jumps 38% in a Year: What's Behind the Surge?

DGX outperforms the industry and the S&P 500 composite's gain in the past year, driven by strong core performance and contributions from acquisitions.

Zacks | 1 year ago
Is it Apt to Hold Quest Diagnostics Stock in Your Portfolio Now?

Is it Apt to Hold Quest Diagnostics Stock in Your Portfolio Now?

DGX stays on investors' radars due to its robust prospects in Advanced Diagnostics and progress in the acquisition strategy.

Zacks | 1 year ago
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term

Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Quest Diagnostics Stock to Gain From Innovation Amid Industry Threats

Quest Diagnostics Stock to Gain From Innovation Amid Industry Threats

Within brain health, the robust demand for AD-detect blood tests for assessing Alzheimer's disease risk drives solid growth for DGX in the fourth quarter of 2024.

Zacks | 1 year ago
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock

Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Quest Diagnostics (DGX) is a Great Momentum Stock: Should You Buy?

Quest Diagnostics (DGX) is a Great Momentum Stock: Should You Buy?

Does Quest Diagnostics (DGX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 1 year ago
Loading...
Load More